Associate Professor Mark Cowley is Deputy Director, Enabling Platforms and Collaboration at Children’s Cancer Institute (CCI). He joined CCI in 2018 to head the Computational Biology Group, and is also a Lead Investigator and co-head of the Luminesce Alliance Data Enabling Platform, president of AGTA (peak genomics body in the region) and co-head of the ACRF Child Cancer Liquid Biopsy Program.

Mark is the Genome Informatics and Data Enabling Platforms lead for the Zero Childhood Cancer Program, overseeing creation of novel analytical approaches and systems that enable real-time analysis of Whole Genome, Transcriptome and Methylome data for every childhood cancer patient in Australia. Mark has been an early adopter of sequencing methods in Australia, establishing some of the world’s first clinically accredited WGS-based diagnostic tests. Mark’s recent projects, many supported by the Luminesce Alliance, have improved analysis of children’s cancer data, producing tools to detect features such as non-coding, splicing, mitochondrial and structural mutations.